KAREN DWYER: Open Payments
NPI 1336191964 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 52 payments from 12 companies in 2025. Trend: 2023 $526 · 2024 $776 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $221 |
| AstraZeneca Pharmaceuticals LP | 10 | $211 |
| Tempus AI, Inc | 8 | $160 |
| Astellas Pharma US Inc | 5 | $108 |
| ABBVIE INC. | 4 | $92 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Genmab U.S., Inc. | 3 | $59 |
| pharmaand GmbH | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Eisai Inc. | 1 | $24 |
Products named: KEYTRUDA, XT CDX, LYNPARZA, Veozah, Enhertu, ELAHERE, Tivdak, Rubraca.
Industry payments across NM — which companies pay providers there.
